Our passion is driving innovative technologies that create efficiencies, while never forgetting that at the heart of every breast cancer journey is a patient.
Today, Mammotome remains committed to advancing breast care by discovering new opportunities to deliver better solutions. We strive to be the trusted leader in breast cancer diagnostics and surgical solutions, accomplished through strong product performance, trusted partnerships and an unwavering focus on patient outcomes.
A proud operating company of Danaher Corporation since 2014, Mammotome is headquartered in Cincinnati, Ohio. The Mammotome brand is sold in over 45 different countries throughout the world. To date, more than 10 million women worldwide have had a procedure using a minimally invasive Mammotome breast biopsy system.
The Mammotome team comes from a diverse array of backgrounds and experiences, but together, we all share a strong commitment to our core values.